October 1, 2016
The FDA has approved Abbott’s FreeStyle Libre Pro, a continuous glucose monitoring system for health care providers to use with their patients with diabetes, the company announced in a press release.
The FreeStyle Libre Pro system is part of Abbott's FreeStyle family of products, including the sensing technology for consumers, the FreeStyle Libre system. The sensor continuously measures glucose in interstitial fluid through a small (5 mm long, 0.4 mm wide) filament that is inserted just under the skin. The device records glucose levels every 15 minutes, capturing up to 1,340 glucose results for up to 14 days, giving the treating provider comprehensive data for a complete glycemic profile of the patient.